Ads
-
Related paper
- Is HMG-Co A Reductase Inhibitor Use Associated with Improved Outcomes in Patients Undergoing Colorectal Cancer Resection?
- Preoperative and Postoperative N-terminal Pro B-type Natriuretic Peptide Levels Predict Cardiac Morbidity and Mortality in Patients Undergoing Colorectal Cancer Resection
- MULTIVISCERAL RESECTION FOR COLORECTAL CANCERS: AN ANALYSIS OF PROGNOSTIC FACTORS AND OUTCOMES
- Identifying Surgery and Anesthesia - Related Anxiety in Patients Undergoing Colorectal Cancer Surgery
- Fatty Acid Synthase Inhibitor Cerulenin Suppresses Colorectal Cancer in Combination with Oxaliplatin
- EVALUATION SOME OF IMMUNOLOGICAL PARAMETERS IN BENIGN PROSTATIC HYPERPLASIA PATIENTS TREATED WITH 5 ALPH-REDUCTASE INHIBITOR (FINASTERIDE)
- End to End (Double stapled) Versus End to Side (Triple Stapled) Colorectal Anastomosis Following Anterior Resection for Rectal Cancer
- Combination of Liver Resection with Methods of Local Thermal destruction in the Treatment of Metastases of Colorectal Cancer in the Liver | Biomedgrid
- Expression of FGF19 gene as an effective gene for the invasive behavior of cancer cells in patients with colorectal cancer
- Stable and Bio-equivalent Formulation of HMG-CoA reductase inhibitor: Atorvastatin Calcium